Immunomagnetic Delivery of Adipose-Derived Endothelial Progenitor Cells for the Repair of Renal Ischemia-Reperfusion Injury in a Rat Model

Overview

Journal Bioengineering (Basel)

Date 2023 May 27

PMID 37237579

Authors

Di Wu

Jingyu Liu

Changcheng Zhou

Wenjie Ma

Liuhua Zhou

Yuzheng Ge

Ruipeng Jia

Affiliations

Soon will be listed here.

Abstract

Renal ischemia-reperfusion injury (IRI) is a significant cause of acute kidney injury (AKI) and usually brings severe public health consequences. Adipose-derived endothelial progenitor cell (AdEPCs) transplantation is beneficial for AKI but suffers from low delivery efficiency. This study was conducted to explore the protective effects of magnetically delivered AdEPCs on the repair of renal IRI. Two types of magnetic delivery methods, namely the endocytosis magnetization (EM) method and the immunomagnetic (IM) method were fabricated using PEG@FeO and CD133@FeO, and their cytotoxicities in AdEPCs were assessed. In the renal IRI rat model, magnetic AdEPCs were injected via the tail vein and a magnet was placed beside the injured kidney for magnetic guidance. The distribution of transplanted AdEPCs, renal function, and tubular damage were evaluated. Our results suggested that CD133@FeO had the minimum negative effects on the proliferation, apoptosis, angiogenesis, and migration of AdEPCs compared with PEG@FeO. Renal magnetic guidance could significantly enhance the transplantation efficiency and the therapeutic outcomes of AdEPCs-PEG@FeO and AdEPCs-CD133@FeO in the injured kidneys. However, under renal magnetic guidance, AdEPCs-CD133@FeO had stronger therapeutic effects than PEG@FeO after renal IRI. The immunomagnetic delivery of AdEPCs with CD133@FeO could be a promising therapeutic strategy for renal IRI.

References

Friedrich E, Walenta K, Scharlau J, Nickenig G, Werner N . CD34-/CD133+/VEGFR-2+ endothelial progenitor cell subpopulation with potent vasoregenerative capacities. Circ Res. 2006; 98(3):e20-5. DOI: 10.1161/01.RES.0000205765.28940.93. View

Zhang Y, Huang H, Liu W, Liu S, Wang X, Diao Z . Endothelial progenitor cells-derived exosomal microRNA-21-5p alleviates sepsis-induced acute kidney injury by inhibiting RUNX1 expression. Cell Death Dis. 2021; 12(4):335. PMC: 8009943. DOI: 10.1038/s41419-021-03578-y. View

Peichev M, Naiyer A, Pereira D, Zhu Z, Lane W, Williams M . Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood. 2000; 95(3):952-8. View

Malek M, Nematbakhsh M . Renal ischemia/reperfusion injury; from pathophysiology to treatment. J Renal Inj Prev. 2015; 4(2):20-7. PMC: 4459724. DOI: 10.12861/jrip.2015.06. View

Zhang B, Jiang H, Chen J, Hu Q, Yang S, Liu X . Silica-coated magnetic nanoparticles labeled endothelial progenitor cells alleviate ischemic myocardial injury and improve long-term cardiac function with magnetic field guidance in rats with myocardial infarction. J Cell Physiol. 2019; 234(10):18544-18559. PMC: 6617719. DOI: 10.1002/jcp.28492. View

Patschan D, Patschan S, Wessels J, Becker J, David S, Henze E . Epac-1 activator 8-O-cAMP augments renoprotective effects of syngeneic [corrected] murine EPCs in acute ischemic kidney injury. Am J Physiol Renal Physiol. 2009; 298(1):F78-85. PMC: 3774182. DOI: 10.1152/ajprenal.00485.2009. View

Zhou L, Xia J, Qiu X, Wang P, Jia R, Chen Y . In vitro evaluation of endothelial progenitor cells from adipose tissue as potential angiogenic cell sources for bladder angiogenesis. PLoS One. 2015; 10(2):e0117644. PMC: 4338275. DOI: 10.1371/journal.pone.0117644. View

Behrooz A, Syahir A, Ahmad S . CD133: beyond a cancer stem cell biomarker. J Drug Target. 2018; 27(3):257-269. DOI: 10.1080/1061186X.2018.1479756. View

Song H, Kim D, Abbasi S, Latifi Gharamaleki N, Kim E, Jin C . Multi-target cell therapy using a magnetoelectric microscale biorobot for targeted delivery and selective differentiation of SH-SY5Y cells magnetically driven cell stamping. Mater Horiz. 2022; 9(12):3031-3038. PMC: 9704487. DOI: 10.1039/d2mh00693f. View

10.

Li B, Cohen A, Hudson T, Motlagh D, Amrani D, Duffield J . Mobilized human hematopoietic stem/progenitor cells promote kidney repair after ischemia/reperfusion injury. Circulation. 2010; 121(20):2211-20. PMC: 2919223. DOI: 10.1161/CIRCULATIONAHA.109.928796. View

11.

Chen K, Li Y, Xu L, Qian Y, Liu N, Zhou C . Comprehensive insight into endothelial progenitor cell-derived extracellular vesicles as a promising candidate for disease treatment. Stem Cell Res Ther. 2022; 13(1):238. PMC: 9172199. DOI: 10.1186/s13287-022-02921-0. View

12.

Chen L, Wu Y, Wu H, Li J, Xie J, Zang F . Magnetic targeting combined with active targeting of dual-ligand iron oxide nanoprobes to promote the penetration depth in tumors for effective magnetic resonance imaging and hyperthermia. Acta Biomater. 2019; 96:491-504. DOI: 10.1016/j.actbio.2019.07.017. View

13.

Pongrac I, Pavicic I, Milic M, Brkic Ahmed L, Babic M, Horak D . Oxidative stress response in neural stem cells exposed to different superparamagnetic iron oxide nanoparticles. Int J Nanomedicine. 2016; 11:1701-15. PMC: 4853020. DOI: 10.2147/IJN.S102730. View

14.

Canizo M, Lozano F, Gonzalez-Porras J, Barros M, Lopez-Holgado N, Briz E . Peripheral endothelial progenitor cells (CD133 +) for therapeutic vasculogenesis in a patient with critical limb ischemia. One year follow-up. Cytotherapy. 2007; 9(1):99-102. DOI: 10.1080/14653240601034708. View

15.

Verma J, Lal S, van Noorden C . Nanoparticles for hyperthermic therapy: synthesis strategies and applications in glioblastoma. Int J Nanomedicine. 2014; 9:2863-77. PMC: 4061173. DOI: 10.2147/IJN.S57501. View

16.

Liu M, Yu W, Zhang F, Liu T, Li K, Lin M . FeO@Polydopamine-Labeled MSCs Targeting the Spinal Cord to Treat Neuropathic Pain Under the Guidance of a Magnetic Field. Int J Nanomedicine. 2021; 16:3275-3292. PMC: 8123975. DOI: 10.2147/IJN.S296398. View

17.

Ottersbach A, Mykhaylyk O, Heidsieck A, Eberbeck D, Rieck S, Zimmermann K . Improved heart repair upon myocardial infarction: Combination of magnetic nanoparticles and tailored magnets strongly increases engraftment of myocytes. Biomaterials. 2017; 155:176-190. DOI: 10.1016/j.biomaterials.2017.11.012. View

18.

Arici V, Perotti C, Fabrizio C, Del Fante C, Ragni F, Alessandrino F . Autologous immuno magnetically selected CD133+ stem cells in the treatment of no-option critical limb ischemia: clinical and contrast enhanced ultrasound assessed results in eight patients. J Transl Med. 2015; 13:342. PMC: 4630831. DOI: 10.1186/s12967-015-0697-4. View

19.

Wei H, Hu Y, Wang J, Gao X, Qian X, Tang M . Superparamagnetic Iron Oxide Nanoparticles: Cytotoxicity, Metabolism, and Cellular Behavior in Biomedicine Applications. Int J Nanomedicine. 2021; 16:6097-6113. PMC: 8418330. DOI: 10.2147/IJN.S321984. View

20.

Bacakova L, Zarubova J, Travnickova M, Musilkova J, Pajorova J, Slepicka P . Stem cells: their source, potency and use in regenerative therapies with focus on adipose-derived stem cells - a review. Biotechnol Adv. 2018; 36(4):1111-1126. DOI: 10.1016/j.biotechadv.2018.03.011. View